GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Equity-to-Asset

Hualan Biological Engineering (SZSE:002007) Equity-to-Asset : 0.73 (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hualan Biological Engineering's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥12,172 Mil. Hualan Biological Engineering's Total Assets for the quarter that ended in Mar. 2025 was ¥16,639 Mil. Therefore, Hualan Biological Engineering's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.73.

The historical rank and industry rank for Hualan Biological Engineering's Equity-to-Asset or its related term are showing as below:

SZSE:002007' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.68   Med: 0.84   Max: 0.91
Current: 0.73

During the past 13 years, the highest Equity to Asset Ratio of Hualan Biological Engineering was 0.91. The lowest was 0.68. And the median was 0.84.

SZSE:002007's Equity-to-Asset is ranked better than
57.54% of 1505 companies
in the Biotechnology industry
Industry Median: 0.68 vs SZSE:002007: 0.73

Hualan Biological Engineering Equity-to-Asset Historical Data

The historical data trend for Hualan Biological Engineering's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Equity-to-Asset Chart

Hualan Biological Engineering Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.72 0.71 0.71 0.73

Hualan Biological Engineering Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.72 0.73 0.73 0.73

Competitive Comparison of Hualan Biological Engineering's Equity-to-Asset

For the Biotechnology subindustry, Hualan Biological Engineering's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Engineering's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's Equity-to-Asset falls into.


;
;

Hualan Biological Engineering Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hualan Biological Engineering's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=11858.784/16309.951
=0.73

Hualan Biological Engineering's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=12172.137/16638.921
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hualan Biological Engineering  (SZSE:002007) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Hualan Biological Engineering Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
Chen Zheng Yue Executives
Fan Bei Directors, executives
Pan Ruo Wen Executives
Xie Jun Min Directors, executives
An Wen Qi Executives
An Kang Directors, executives
Ma Xiao Wei Executives
Zhang Bao Xian Executives
An Wen Jue Director
Liu Jun Executives
Wang Qi Ping Directors, executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors

Hualan Biological Engineering Headlines

No Headlines